Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL
Clinical trial NCT05478512 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05478512
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-21
- Primary completion
- 2026-05-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.